)
Trisalus Life Sciences (TLSI) investor relations material
Trisalus Life Sciences Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and technology
Focuses on high-margin, high-growth oncology with pressure-enabled drug delivery technology for tumors, improving patient outcomes and reducing impact on normal tissue.
Holds over 100 patents, with 20-25 new patents filed annually, and a multi-layered IP portfolio.
Addresses the challenge of drug delivery to solid tumors by modulating pressure and flow, increasing drug concentration in tumors by 50%-500%.
Technology features a flexible, anti-reflux catheter system that enables homogeneous drug perfusion.
Cleared for embolization procedures except in coronary and neurovasculature; expansion possible with further approvals.
Market opportunity and reimbursement
Targets a $2.5 billion market, currently with 9% share in liver applications and significant growth potential.
Achieved favorable reimbursement, including a proprietary CMS code and $8,000 per catheter pricing, with hospitals saving $8,000 per procedure.
Demonstrated 50% reduction in 30-day hospital readmissions and improved patient outcomes, including less fatigue and higher liver transplantation rates.
Commercial payers reimburse $20,000-$40,000 per procedure, making it revenue-enhancing for hospitals.
Highly concentrated market with 400 hospitals and 1,000 doctors; field force of about 50 people.
Product portfolio and new applications
Expanded from two to a full portfolio of devices, enabling treatment of diverse vascular anatomies and new indications.
Technology adapted for uterine fibroids, multinodular goiter, and genicular artery embolization, with rapid product development cycles.
Uterine fibroid application allows high-flow perfusion and minimally invasive treatment, preserving fertility.
Multinodular goiter treatment avoids surgery and preserves thyroid function.
Genicular artery embolization delays knee replacement and reduces opioid prescriptions, with potential to transform orthopedics.
Next Trisalus Life Sciences earnings date
Next Trisalus Life Sciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage